Abstract

Allopurinol is the most commonly used medication to treat hyperuricaemia as a cause of gout. One of the challenging aspects of initiating allopurinol therapy is that treatment can precipitate flares, and can therefore do the opposite of what it is intended for—a situation that patients can understandably find confusing. To reduce the likelihood of flares, allopurinol needs to be started at a low dose and uptitrated; anti-inflammatory prophylaxis, such as colchicine, needs to be co-prescribed; and a treatment plan for managing flares should be given to the patient.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.